pmc-enju-pas Home  

PMC:3586680 / 116-645 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T182 9-16 VB denotes mutated
T183 17-19 IN denotes in
T184 20-33 NN denotes glioblastomas
T185 34-35 -LRB- denotes (
T186 35-39 NN denotes GBMs
T187 39-40 -RRB- denotes )
T188 41-44 CC denotes and
T189 45-52 VB denotes appears
T190 53-55 TO denotes to
T191 56-66 VB denotes contribute
T192 66-67 -COMMA- denotes ,
T193 68-70 IN denotes in
T194 71-75 NN denotes part
T195 75-76 -COMMA- denotes ,
T196 77-79 TO denotes to
T197 80-90 NN denotes resistance
T198 91-93 TO denotes to
T199 94-106 NN denotes temozolomide
T200 107-108 -LRB- denotes (
T201 108-111 NN denotes TMZ
T202 111-112 -RRB- denotes )
T203 113-116 CC denotes and
T204 117-128 JJ denotes therapeutic
T205 129-134 NN denotes drugs
T206 136-138 JJ denotes WW
T207 139-156 JJ denotes domain-containing
T208 157-171 NN denotes oxidoreductase
T209 172-176 NN denotes WWOX
T210 177-178 -LRB- denotes (
T211 178-181 NN denotes FOR
T212 182-184 CC denotes or
T213 185-189 NN denotes WOX1
T214 189-190 -RRB- denotes )
T215 191-193 VB denotes is
T216 194-195 DT denotes a
T217 196-208 JJ denotes proapoptotic
T218 209-216 NN denotes protein
T219 217-220 CC denotes and
T220 221-223 VB denotes is
T221 224-234 VB denotes considered
T222 235-237 IN denotes as
T223 238-239 DT denotes a
T224 240-245 NN denotes tumor
T225 246-256 NN denotes suppressor
T226 258-262 NN denotes Loss
T227 263-265 IN denotes of
T228 266-270 NN denotes WWOX
T229 271-275 NN denotes gene
T230 276-286 NN denotes expression
T231 287-289 VB denotes is
T232 290-300 RB denotes frequently
T233 301-305 VB denotes seen
T234 306-308 IN denotes in
T235 309-318 JJ denotes malignant
T236 319-325 NN denotes cancer
T237 326-331 NN denotes cells
T238 332-335 JJ denotes due
T239 336-338 TO denotes to
T240 339-347 NN denotes promoter
T241 348-364 NN denotes hypermethylation
T242 364-365 -COMMA- denotes ,
T243 366-373 JJ denotes genetic
T244 374-385 NN denotes alterations
T245 385-386 -COMMA- denotes ,
T246 387-390 CC denotes and
T247 391-404 JJ denotes translational
T248 405-413 NN denotes blockade
T249 415-427 RB denotes Intriguingly
T250 427-428 -COMMA- denotes ,
T251 429-436 JJ denotes ectopic
T252 437-447 NN denotes expression
T253 448-450 IN denotes of
T254 451-455 JJ denotes wild
T255 456-460 NN denotes type
T256 461-465 NN denotes WWOX
T257 466-480 RB denotes preferentially
T258 481-488 VB denotes induces
T259 489-498 NN denotes apoptosis
T260 499-501 IN denotes in
T261 502-507 JJ denotes human
T262 508-520 NN denotes glioblastoma
T263 521-526 NN denotes cells
R100 T237 T234 arg2Of cells,in
R101 T237 T235 arg1Of cells,malignant
R102 T237 T236 arg1Of cells,cancer
R103 T237 T238 arg1Of cells,due
R104 T241 T240 arg1Of hypermethylation,promoter
R105 T241 T242 arg1Of hypermethylation,","
R106 T242 T246 arg1Of ",",and
R107 T244 T242 arg2Of alterations,","
R108 T244 T243 arg1Of alterations,genetic
R109 T246 T239 arg2Of and,to
R110 T246 T245 arg1Of and,","
R111 T248 T246 arg2Of blockade,and
R112 T248 T247 arg1Of blockade,translational
R113 T252 T251 arg1Of expression,ectopic
R114 T252 T253 arg1Of expression,of
R115 T252 T258 arg1Of expression,induces
R116 T256 T253 arg2Of WWOX,of
R117 T256 T254 arg1Of WWOX,wild
R118 T256 T255 arg1Of WWOX,type
R119 T258 T249 arg1Of induces,Intriguingly
R120 T258 T250 arg1Of induces,","
R121 T258 T257 arg1Of induces,preferentially
R122 T258 T260 arg1Of induces,in
R123 T259 T258 arg2Of apoptosis,induces
R124 T263 T260 arg2Of cells,in
R125 T263 T261 arg1Of cells,human
R126 T263 T262 arg1Of cells,glioblastoma
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic
R69 T209 T206 arg1Of WWOX,WW
R70 T209 T207 arg1Of WWOX,domain-containing
R71 T209 T208 arg1Of WWOX,oxidoreductase
R72 T209 T210 arg1Of WWOX,(
R73 T209 T215 arg1Of WWOX,is
R74 T209 T220 arg1Of WWOX,is
R75 T209 T221 arg2Of WWOX,considered
R76 T211 T212 arg1Of FOR,or
R77 T212 T210 arg2Of or,(
R78 T213 T212 arg2Of WOX1,or
R79 T214 T210 arg3Of ),(
R80 T215 T219 arg1Of is,and
R81 T218 T215 arg2Of protein,is
R82 T218 T216 arg1Of protein,a
R83 T218 T217 arg1Of protein,proapoptotic
R84 T221 T219 arg2Of considered,and
R85 T221 T220 arg2Of considered,is
R86 T221 T222 arg1Of considered,as
R87 T225 T222 arg2Of suppressor,as
R88 T225 T223 arg1Of suppressor,a
R89 T225 T224 arg1Of suppressor,tumor
R90 T226 T227 arg1Of Loss,of
R91 T226 T231 arg1Of Loss,is
R92 T226 T233 arg2Of Loss,seen
R93 T230 T227 arg2Of expression,of
R94 T230 T228 arg1Of expression,WWOX
R95 T230 T229 arg1Of expression,gene
R96 T233 T231 arg2Of seen,is
R97 T233 T232 arg1Of seen,frequently
R98 T233 T234 arg1Of seen,in
R99 T233 T239 arg1Of seen,to